Suchergebnisse - (Standardsuche:issn:"1756-8919" OR issn:"1756-8927")

PubPharm (158)

81

Zwitterionic structures : from physicochemical properties toward computer-aided drug designs

enthalten in: Future medicinal chemistry | 2016

von Yang, Z. | Li, Q. | Yang, G.

82

Recently discovered EZH2 and EHMT2 (G9a) inhibitors

enthalten in: Future medicinal chemistry | 2016

von Soumyanarayanan, U. | Dymock, B.

83

Histone acetyltransferase inhibitors : where art thou?

enthalten in: Future medicinal chemistry | 2016

von Baell, J. | Miao, W.

84

H3K36 methyltransferases as cancer drug targets : rationale and perspectives for inhibitor development

enthalten in: Future medicinal chemistry | 2016

von Rogawski, D. | Grembecka, J. | Cierpicki, T.

85

Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes

enthalten in: Future medicinal chemistry | 2016

von Qian, S. | Zhang, M. | He, Y. | +2

86

Characterization of chemical features of potent myeloperoxidase inhibitors

enthalten in: Future medicinal chemistry | 2016

von Soubhye, J. | Meyer, F. | Furtmüller, P. | +3

87

New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition

enthalten in: Future medicinal chemistry | 2016

von Estrada, M. | Pérez, C. | Soriano, E. | +6

88

New Delhi metallo-β-lactamase-1 : structure, inhibitors and detection of producers

enthalten in: Future medicinal chemistry | 2016

von Groundwater, P. | Xu, S. | Lai, F. | +4

89

The analysis of the antibiotic resistome offers new opportunities for therapeutic intervention

enthalten in: Future medicinal chemistry | 2016

von Corona, F. | Blanco, P. | Alcalde-Rico, M. | +5

90

Inhibitors of enzymes catalyzing modifications to histone lysine residues : structure, function and activity

enthalten in: Future medicinal chemistry | 2016

von Lillico, R. | Stesco, N. | Khorshid Amhad, T. | +3